Arkolith/Insider Trading/PCRX/Form 4

Cross Shawn

Chief Financial OfficerPacira BioSciences, Inc. (PCRX) · full profile →Form 4 · filed Apr 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$326K
Net Open-Market Flow
-$326K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 23, 2026Option exercise(M)13K$16.45$213K118K
Apr 23, 2026Sell(S)13K$25.16$326K105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 23, 2026Option exercise(M)13K—$0150K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-027287) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML